Publication

H63D polymorphism in HFE is not associated with amyotrophic lateral sclerosis

Journal Paper/Review - Oct 11, 2012

Units
PubMed
Doi

Citation
van Rheenen W, de Visser M, Weber M, Robberecht W, Hardiman O, Shaw P, Shaw C, Morrison K, Al-Chalabi A, Andersen P, Ludolph A, Veldink J, van der Kooi A, Schelhaas H, Waibel S, Diekstra F, van Doormaal P, Seelen M, Kenna K, McLaughlin R, Shatunov A, Czell D, van Es M, van Vught P, Van Damme P, Smith B, van den Berg L. H63D polymorphism in HFE is not associated with amyotrophic lateral sclerosis. Neurobiol Aging 2012; 34:1517.e5-7.
Type
Journal Paper/Review (English)
Journal
Neurobiol Aging 2012; 34
Publication Date
Oct 11, 2012
Issn Electronic
1558-1497
Pages
1517.e5-7
Brief description/objective

The H63D polymorphism in HFE has frequently been associated with susceptibility to amyotrophic lateral sclerosis (ALS). Regarding the role of HFE in iron homeostasis, iron accumulation is considered an important process in ALS. Furthermore, novel therapeutic strategies are being developed targeting this process. Evidence for this genetic association is, however, limited to several small studies. For this reason we studied the H63D polymorphism in a large European cohort including 3962 ALS patients and 5072 control subjects from 7 countries. After meta-analysis of previous studies and current findings we conclude that the H63D polymorphism in HFE is not associated with susceptibility to ALS, age at disease onset, or survival.